Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by Danorrnon Feb 07, 2019 7:00pm

102 Views

Post# 29335293

RE:RE:WOW !!! RSI is off OVERSOLD chart at 23.98

All stocks follow TA, heck the Chinese sold rice using technicals you just can't rely on RSI alone. The MACD is still negative but I see a slight bend which I'm hoping turns upward soon. The positive thing I do see is for three days we've see higher highs and higher lows. Two days ago we had a long legged doji at the bottom of the bought deal announcement pp collapse. The doji was confirmed as a change in sentiment the next day and today with positive movement upward. I guess there have been people selling to buy into the bought deals but the chart was turning down prior to the announcement. I thought about selling but I'm long and I've forgotten when news about the latest results are due. Glta

Bullboard Posts

5 steps to mastering risk management in the stock market